1. Home
  2. STTK vs PDYN Comparison

STTK vs PDYN Comparison

Compare STTK & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.00

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$6.31

Market Cap

291.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
PDYN
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
291.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
PDYN
Price
$6.00
$6.31
Analyst Decision
Buy
Hold
Analyst Count
7
1
Target Price
$7.60
$8.00
AVG Volume (30 Days)
589.2K
2.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
$199.22
Revenue Next Year
N/A
$104.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$4.14
52 Week High
$6.27
$12.79

Technical Indicators

Market Signals
Indicator
STTK
PDYN
Relative Strength Index (RSI) 71.72 43.46
Support Level $1.85 $4.39
Resistance Level N/A $9.78
Average True Range (ATR) 0.42 0.71
MACD 0.09 -0.19
Stochastic Oscillator 89.41 2.81

Price Performance

Historical Comparison
STTK
PDYN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

Share on Social Networks: